Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

INTERIM REPORT 1 JANUARY–30 JUNE 2019

CONTINUED GOOD GROWTH AND STABLE EBITA MARGINSECOND QUARTER SUMMARY, APRIL–JUNE 2019 • Net sales increased by 21 per cent to SEK 864 m (717), of which 15 per cent was organic. Currency-adjusted organic growth was 13 per cent. • EBITA increased to SEK 74 m (62), for an EBITA margin of 8.6 per cent (8.6). • Operating profit increased to SEK 46 m (39), for an operating margin of 5.3 per cent (5.4). • Profit after tax increased to SEK 33 m (28). • Earnings per share increased to SEK 0.99 (0.91). • Cash flow from operating activities totalled SEK -20 m (27). • Acquisition of

Notice to attend the annual general meeting of Addtech AB (publ)

The shareholders of Addtech AB (publ), reg. no. 556302-9726, are hereby given notice to attend the Annual General Meeting to be held at 1:00 pm CET on Thursday the 29 August 2019, at IVA’s Konferenscenter, Grev Turegatan 16, Stockholm. Registration for the meeting commences at 12:30 pm CET. NOTICE OF PARTICIPATION Shareholders who wish to attend in the proceedings of the Annual General Meeting must: ·  be entered in the shareholders’ register kept on behalf of the company by Euroclear Sweden AB, as of Friday, 23 August 2019; and ·  notify the Company’s head office at Addtech

Getinge announces full market release of Servo-u 4.0 featuring innovations for personalized lung protection

Getinge announced today the full market release for the latest version of Servo-u 4.0, an innovative mechanical ventilator with groundbreaking solutions for automatic lung recruitment and transpulmonary pressure monitoring. The full release means that Auto SRM (Automatic Stepwise Recruitment Maneuver) is now commercially available to all markets not requiring additional regulatory submission, in addition to the CE-mark.“This release marks yet another milestone in Getinge’s extensive legacy of clinical innovations for Intensive Care Units worldwide,” says Jens Viebke, President Acute Care

NetEnt games live in Pennsylvania, USA

As expected, the new regulated online gambling market in Pennsylvania has opened. After successful integrations, NetEnt’s games are now live in the US state.In March this year, NetEnt, through its subsidiary NetEnt Americas LLC, was granted an Interactive Gaming Manufacturer Conditional License by the Pennsylvania Gaming Control Board (PGCB). Pennsylvania is the second large US state to regulate online casino and with almost 13 million people, it is the fifth largest state by population. The state has a long tradition of gambling on the land-based side. As previously communicated, NetEnt

INTERIM REPORT 1 APRIL– 30 JUNE 2019

“We will continue to explore commercialization opportunities for our imaging technology, and we took a first, and very important, step very recently though our first strategic partnership. The orthopaedic industry is dominated by a small number of large, global players. As we have previously communicated, at the right time the company is open to seeking a partnership for some or all of its products in key markets.” Second quarter 2019 compared to 2018, Group » Gross order intake amounted to SEK 1.3m (1.1) an increase of 21.0% » Order backlog amounted to SEK 0.7m (1.1) » 14,0%

Stora Enso Oyj Half-year Report January–June 2019

STORA ENSO OYJ, Helsinki, Finland HALF-YEAR FINANCIAL REPORT 19 July 2019 at 9.30 EESTFit for the future, protecting profit and cash flowBergvik Skog transaction completedQ2/2019 (compared with Q2/2018) · Sales decreased by 2.1% to EUR 2 608 (2 664) million. · Operational EBIT margin was 11.0% (12.3%), above 10% for the eighth consecutive quarter. Operational EBIT was EUR 287 (327) million. · Operating profit (IFRS) was EUR 142 (317) million. · EPS decreased to EUR 0.08 (0.28) and EPS excl. IAC was EUR 0.22 (0.31). · Strong cash flow from operations amounted to EUR 548 (

Stora Enso evaluates expansion in Wood Products

STORA ENSO OYJ INVESTOR NEWS 19 July 2019 at 9.29 EESTStora Enso has initiated feasibility studies for a possible cross laminated timber (CLT) unit in connection with its Ždírec mill in the Czech Republic and a new construction beam unit to be located at the Ybbs mill in Austria. Stora Enso also plans to consolidate production to increase focus on efficiency and to streamline the asset base. Stora Enso continues its transformation into a leading provider of innovative wood-based solutions. The transformation in Wood Products includes both selected growth in added-value businesses and

Stora Enso invests in producing bio-based carbon materials for energy storage

STORA ENSO OYJ INVESTOR NEWS 19 July 2019 at 9.29 EESTStora Enso is investing EUR 10 million to build a pilot facility for producing bio-based carbon materials based on lignin. Wood-based carbon can be utilised as a crucial component in batteries typically used in consumer electronics, the automotive industry and large-scale energy storage systems. The pilot plant will be located at Stora Enso’s Sunila Mill in Finland. The investment in making carbon materials for energy storage further strengthens Stora Enso’s opportunities to replace fossil-based and mined raw materials as well as to

Cyxone makes further strides with Rabeximod phase IIb trial by signing CRO EGeen Inc.

Cyxone (publ), a Swedish biotech in autoimmune diseases, today announced that the company has signed an agreement with EGeen Inc., a clinical research organization (CRO), for conducting its upcoming clinical phase IIb trial with Rabeximod in rheumatoid arthritis (RA) in select Eastern European countries. Cyxone is now, together with several partners, finalizing the necessary applications for permission to run its phase IIb multicenter study in both Western and Eastern Europe. The first application has been submitted and the remaining, up to eight, applications are expected to be submitted

Gunnebo Interim Report April-June 2019

Strong sales development and improved result in the second quarter. Cost-efficiency programme launched to accelerate margins improvement.President and CEO Henrik Lange Comments on Q2 2019: Order intake continued to have a positive development of 5% (2% in constant currencies), where both Entrance Control and Safe Storage showed double-digit growth of 14%. For Cash Management order intake in the US and Asia-Pacific was slow. This is expected to improve in the second half of the year. For Integrated Security, which had a contraction of order intake in the quarter, order levels fluctuate

Attendo’s report for the second quarter 2019:Challenges in Finland pressures profitability

Attendo reports continued healthy growth but also considerably lower profit during the second quarter of 2019. The lower result is mainly explained by structural cost increases and challenges related to the rapid growth in the Finnish operations. Meanwhile, Attendo Scandinavia is showing a steady development.President and CEO Martin Tivéus comments on the report “The first half of the year has been very challenging for Attendo's Finnish operations, which is not least visible in the second quarter. As we announced in June, we are taking forceful actions in order to restore occupancy and

Episurf Medical enters into its first strategic partnership regarding its AI-based imaging technology

Episurf Medical (NASDAQ: EPIS B) today announces that it has entered into a Letter of Intent with a US-based orthopaedic company related to Episurf Medical’s proprietary and patented imaging technology, now to be applied for the allograft industry. While the details and financial considerations of the Letter of Intent are currently confidential, both parties have the intention to collaborate using Episurf Medical’s Epioscopy® technology platform for surgery planning within allograft joint surgery. In September 2018, Episurf Medical announced that the company had CE-marked its

Fortum Half-year Financial Report 2019 - Improved results in all business segments and strong cash flow

FORTUM CORPORATION HALF-YEAR FINANCIAL REPORT JANUARY-JUNE 2019 19 JULY 2019 AT 9:00 EEST Release category: Half-year financial report This release is a summary of Fortum’s Half-year Financial Report 2019. The complete report is attached to this release as a pdf-file. It is also available on the company's website at www.fortum.com/investors. April-June 2019 · Comparable EBITDA was EUR 372 (282) million, +32% · Comparable operating profit was EUR 232 (153) million, +52% · Operating profit was EUR 184 (256) million, -28% · Share of profits of associated companies and

Interim Report January-June 2019

Improved competitiveness through recruitments and business acquisitionsSecond quarter · Net sales amounted to MSEK 70.0 (61.5), rendering a net sales growth of 14% (19%). Organic net sales growth was 14% (14%) · Recurring revenue amounted to MSEK 41.3 (34.0) · The quarter was impacted by one-off items affecting comparison amounting to MSEK 0.6 (1.2), whereof MSEK 0.6 (0.2) was attributable to acquisitions, and MSEK 0.0 (1.0) was attributable to the listing of the company’s shares on Nasdaq Stockholm · Adjusted EBITA amounted to MSEK 13.8 (11.6) which corresponds to an adjusted

Notice to attend the Annual General Meeting of Lagercrantz Group AB (publ)

The shareholders of Lagercrantz Group AB (publ) (“the Company”) are hereby given notice to attend the Annual General Meeting to be held at 4.00 p.m., on Tuesday, 27 August 2019, at IVA’s Conference Centre, Grev Turegatan 16 in Stockholm.  NOTICE OF PARTICIPATION   Shareholders who wish to participate in the proceedings of the Annual General Meeting (AGM) must: 1)    be entered under their own name (not in the name of a trustee) in the shareholders’ register maintained by Euroclear Sweden AB no later than Wednesday, 21 August 2019.2)    give notice via the website www.

INTERIM REPORT JANUARY – JUNE 2019

THE PERIOD AND THE SECOND QUARTER·Net sales amounted to MSEK 808.2 (756.5), whereof the second quarter MSEK 387.4 (489.4). This corresponds to an increase for the period of 7% and a decrease for the quarter of 21%. Excluding one-off income in the second quarter of 2018, net sales in the second quarter decreased by 4%. ·Adjusted EBITDA amounted to MSEK 290.8 (234.4), whereof the second quarter MSEK 137.8 (145.7). During the second quarter of 2019, the company has also had non-recurring costs related to the acquisition of Trimb and restructuring costs of MSEK 35.3. During the second

MTG portfolio company Kongregate acquires hit mobile and web game Bit Heroes

Friday, July 19, 2019 — Modern Times Group MTG AB portfolio company Kongregate - a cross-platform game publisher and web gaming destination -  today announces the acquisition of Bit Heroes, a successful indie mobile and web role playing game (RPG) from American Reno-based developer Juppiomenz.· The hit game title Bit Heroes has amassed USD 10 million in net revenue and attracted over 14 million game plays since launched in September 2016 · Kongregate to further develop Bit Heroes with new content and expand the games reach through further expansion into Asia · Kongregate and developer

Peab´s half-year report January – June 2019

Higher net sales and improved operating profitApril – June 2019 · Net sales SEK 14,336 million (13,453) · Operating profit SEK 821 million (677), divestiture of property from the partially owned company Acturum has affected operating profit positively by SEK 170 million · Operating margin 5.7 percent (5.0) · Pre-tax profit SEK 811 million (673) · Earnings per share SEK 2.33 (1.94) · Orders received SEK 10,817 million (16,257) · Cash flow before financing SEK -1,321 million (-704) · On July 4th Peab signed an agreement to acquire YIT´s Nordic paving and mineral

Q2 2019: Favourable growth continues in Q2

Significant events in the second quarter · Second-quarter net sales amounted to MSEK 180 (153), an increase of 18% (adjusted for currency effects 15%) compared with the second quarter of 2018 · EBITDA for the second quarter amounted to MSEK 57 (43), an increase of 32% compared with the second quarter of 2018 · A successfully completed clinical trial on 326 healthy pregnant women showed that intake of Probi FerroSorb® significantly improved iron status · New product concept launched in the Nordic market, adapted for consumers of all ages, with the products Probi® Baby, Probi®

Midsona - Interim Report January-June 2019

Strong sales growth for prioritised brandsApril-June 2019 (second quarter) ·  Net sales amounted to SEK 705 million (714). ·  Growth for prioritised brands amounted to 10.2 percent ·  Net sales for the concluded sales assignment Alpro amounted to SEK 2 million (64) ·  EBITDA amounted to SEK 59 million (57) before items affecting comparability, corresponding to a margin of 8.4 percent (8.0). ·  Profit for the period amounted to SEK 23 million (25), corresponding to earnings per share of SEK 0.50 (0.55) before and after dilution. ·  Free cash flow amounted to SEK 75

Conclusions from investigations following Danish media allegations

Background On 8 May 2019, a Danish journalist put forward allegations that a Loomis subsidiary had been providing currencies to foreign exchange offices in Denmark, of which some are suspected to be involved in money laundering. Loomis has not, at any time, been served suspicion from authorities in relation to this matter but takes allegations about money laundering seriously, and therefore immediately launched an internal as well as two separate and independent external investigations. The foreign exchange business in Denmark has been conducted by Loomis Foreign Exchange AS in

Vattenfall – interim report, January–June 2019

Financial highlights, January-June 2019 · Net sales increased by 12% (10% excluding currency effects) to SEK 84,243 million (75,035) · Underlying operating profit of SEK 13,295 million (13,129) · Operating profit of SEK 11,038 million (9,750) · Profit for the period of SEK 7,673 million (7,125) Financial highlights, April-June 2019 · Net sales increased by 11% (10% excluding currency effects) to SEK 34,691 million (31,176) · Underlying operating profit of SEK 3,622 million (3,770) · Operating profit of SEK 2,869 million (2,775) · Profit for the period of SEK 1,

MSAB: Continued investment for growth

January - June · Net sales increased 1.6 percent to SEK 130.4 (128.3) million (-4 percent in local currencies). · EBIT amounted to SEK -17.1 (3.8) million. · The EBIT margin was -13.1 (3.0) percent. · Profit after tax amounted to SEK -15.3 (5.7) million. · Earnings per share amounted to SEK -0.83 (0.31). · Cash flow from operating activities amounted to SEK -6.2 (-11.1) million. · Cash and cash equivalents and short-term investments amounted to SEK 52.5 (80.4) million at the end of the period. Second quarter · Net sales increased 1.7 percent to SEK 64.1 (63.0)

Boliden’s second quarter: Stable production in Mines and maintenance in Smelters

Boliden’s second quarter was characterized by stable production at lower grades in Mines and planned maintenance shutdowns in Smelters. Revenues for the period were SEK 12,747 m (14,071), and the operating profit excluding revaluation of process inventory was SEK 1,631 m (2,329). Free cash flow totalled SEK 789 m (1,718).“In general, production was stable during the quarter. Lower grades in several mines together with planned maintenance shutdowns in our Finnish smelters naturally affected earnings. The result was also impacted by an item affecting comparability for future reclamation work

There are no items matching the current filter
There are no more items matching the current filter
Back to top